10-Q | 2020-09-30 | Filed 2020-10-23 |
10-Q | 2020-06-30 | Filed 2020-07-24 |
10-Q | 2020-03-31 | Filed 2020-04-24 |
10-K | 2019-12-31 | Filed 2020-02-14 |
10-Q | 2019-09-30 | Filed 2019-10-25 |
10-Q | 2019-06-30 | Filed 2019-07-25 |
10-Q | 2019-03-31 | Filed 2019-04-30 |
10-K | 2018-12-31 | Filed 2019-02-19 |
10-Q | 2018-09-30 | Filed 2018-11-06 |
10-Q | 2018-06-30 | Filed 2018-08-07 |
10-Q | 2018-03-31 | Filed 2018-05-08 |
10-K | 2017-12-31 | Filed 2018-02-27 |
10-Q | 2017-09-30 | Filed 2017-11-13 |
10-Q | 2017-06-30 | Filed 2017-08-11 |
10-Q | 2017-03-31 | Filed 2017-05-15 |
10-K | 2016-12-31 | Filed 2017-03-20 |
10-Q | 2016-09-30 | Filed 2016-11-14 |
10-Q | 2016-06-30 | Filed 2016-08-15 |
10-Q | 2016-03-31 | Filed 2016-06-23 |
8-K | 2020-11-13 | |
8-K | 2020-10-23 | |
8-K | 2020-10-01 | |
8-K | 2020-09-21 | |
8-K | 2020-07-24 | |
8-K | 2020-07-01 | |
8-K | 2020-04-24 | |
8-K | 2020-04-21 | |
8-K | 2020-03-27 | |
8-K | 2020-02-14 | |
8-K | 2020-01-16 | |
8-K | 2020-01-16 | |
8-K | 2019-11-22 | |
8-K | 2019-10-31 | |
8-K | 2019-10-29 | |
8-K | 2019-10-24 | |
8-K | 2019-07-25 | |
8-K | 2019-06-17 | |
8-K | 2019-05-22 | |
8-K | 2019-04-30 | |
8-K | 2019-04-25 | |
8-K | 2019-03-14 | |
8-K | 2019-03-12 | |
8-K | 2019-02-14 | |
8-K | 2018-12-10 | |
8-K | 2018-12-04 | |
8-K | 2018-11-02 | |
8-K | 2018-08-03 | |
8-K | 2018-05-04 | |
8-K | 2018-05-04 | |
8-K | 2018-02-22 | |
8-K | 2018-01-18 |
Comps ($MM TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|---|---|---|
20 20 Global (TWGL) | |||||||||||
024 Pharma (EEIG) | |||||||||||
111 (YI) | 0% | 1,546 | 323 | 0 | 0 | 0 | 0 | -854 | |||
1 800 Flowers Com (FLWS) | 944 | 42% | 13.3 | 6% | 665 | 336 | 1,266 | 534 | 37 | 75 | 1,001 |
10x Genomics (TXG) | 4,805 | 75% | -490.3 | -2% | 573 | 151 | 61 | 46 | -10 | -9 | 4,357 |
12 Retech (RETC) | 0 | 32% | -0.1 | -1,385% | 1 | 20 | 1 | 0 | -15 | -15 | 1 |
11 Good Energy (ELVN) | |||||||||||
1347 Property Insurance Holdings (PIH) | 34 | 0% | 0.4 | -5% | 164 | 108 | 18 | 0 | -8 | -8 | -3 |
1347 Capital Corp (TFSC) | |||||||||||
180 Degree Capital (TURN) | |||||||||||
1847 Holdings (EFSH) | 25% | -2.4 | -15% | 19 | 23 | 27 | 7 | -3 | -1 | 3 | |
1895 Bancorp of Wisconsin (BCOW) | 46,153 | 12,508.1 | -0% | 441 | 383 | 0 | 0 | -0 | 4 | 46,142 | |
1st Constitution Bancorp (FCCY) | 165 | 0% | 4.4 | 1% | 1,343 | 1,204 | 0 | 0 | 14 | 33 | 144 |
1st Franklin Financial (FFC) | 4 | -0.6 | 7% | 905 | 645 | 0 | 0 | 62 | 80 | -46 | |
24 7 Kid Doc (TVMD) | |||||||||||
1st Source (SRCE) | 1,200 | 7.9 | 1% | 6,691 | 5,858 | 0 | 0 | 70 | 136 | 1,073 | |
2050 Motors (ETFM) | 0 | -0.2 | -166,272,400% | 0 | 2 | 0 | 0 | -2 | -2 | 0 | |
21Vianet Group (VNET) | 6,005 | 0% | 11,151 | 5,788 | 0 | 0 | 0 | 0 | 3,344 | ||
22nd Century (XXII) | 302 | 1% | -14.1 | -36% | 62 | 7 | 26 | 0 | -22 | -21 | 302 |
1Life Healthcare (ONEM) |
Balance Sheet ($MM) | 2016-03-31 | 2016-06-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash | 0 | 0 | 113 | 135 | 170 | 146 | 132 | 129 | 181 | 202 | 160 | 177 | 160 | 158 |
Accounts Receivable | 174 | 168 | 187 | 197 | 200 | 199 | 230 | 220 | 264 | 223 | 251 | 245 | ||
Inventory | ||||||||||||||
PP&E | ||||||||||||||
Assets | 0 | 0 | 8,714 | 8,960 | 9,174 | 9,382 | 9,578 | 9,681 | 10,110 | 10,348 | 10,270 | 10,110 | 9,996 | 9,802 |
Accounts Payable | 0 | 0 | 3 | 6 | ||||||||||
Long-Term Debt | 6,353 | 6,479 | 6,747 | 6,790 | 6,912 | 6,953 | 7,282 | 7,473 | 7,529 | 7,365 | 7,205 | 6,986 | ||
Liabilities | 0 | 0 | 6,907 | 7,147 | 7,353 | 7,347 | 7,368 | 7,416 | 7,778 | 7,964 | 7,945 | 7,822 | 7,659 | 7,494 |
Stockholders' Equity | 0 | 0 | 1,663 | 1,673 | 1,683 | 1,900 | 2,076 | 2,134 | 2,203 | 2,257 | 2,204 | 2,251 | 2,337 | 2,308 |
Income Statement ($MM) | 2016-03-31 | 2016-06-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Revenue | 0 | 0 | 5 | 13 | 12 | 7 | 13 | 18 | 25 | 18 | 23 | 26 | ||
Cost of Revenue | 5 | 11 | 11 | 6 | 10 | 14 | 19 | 14 | 19 | 22 | ||||
Gross Profit | 0 | 0 | 1 | 1 | 1 | 3 | 4 | 6 | 6 | 4 | 4 | 4 | ||
R&D | ||||||||||||||
SG&A | 0 | 0 | 23 | 22 | 21 | 21 | 20 | 21 | 20 | 18 | 20 | 18 | ||
Tax | 0 | 0 | 7 | 11 | 11 | -123 | 11 | 16 | 10 | 8 | 8 | 5 | ||
Net Income | -0 | 83 | 107 | 96 | 93 | 86 | 91 | |||||||
Cash Flow ($MM) | 2016-03-31 | 2016-06-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash Operating | 0 | 0 | 163 | 195 | 217 | 232 | 231 | 194 | 293 | 296 | 206 | |||
Cash Investing | 0 | 0 | -216 | -330 | -458 | -308 | -205 | -538 | -409 | 6 | -50 | |||
Cash Financing | 0 | 0 | 75 | 169 | 218 | 62 | -6 | 278 | 137 | -284 | -174 |